コンテンツへスキップ
Merck

Pulmonary toxicity of nitrofurantoin.

Archives of physical medicine and rehabilitation (1989-01-01)
C M Witten
要旨

Nitrofurantoin is frequently used by the physiatrist for treatment of urinary tract infections or for urinary antimicrobial prophylaxis. There is a substantial risk of acute and chronic pulmonary side effects with this medication. The acute pulmonary toxicity presents with fever, leukocytosis, dyspnea, and nonproductive cough. Chronic nitrofurantoin use can lead to interstitial pulmonary fibrosis. A case is reported of a 47-year-old spinal cord injured woman with an acute pulmonary reaction to nitrofurantoin. The literature pertaining to pulmonary toxicity of nitrofurantoin is reviewed.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ニトロフラントイン, 98.0-102.0% (EP, UV)
Supelco
ニトロフラントイン, Pharmaceutical Secondary Standard; Certified Reference Material
USP
ニトロフラントイン, United States Pharmacopeia (USP) Reference Standard
Supelco
ニトロフラントイン, VETRANAL®, analytical standard